Polyclonal immunoglobulins for COVID-19 pre-exposure prophylaxis in immunocompromised patients.

ABSTRACT: Immunocompromised patients remain at high risk of COVID-19 morbidity and mortality. After recent Omicron sublineages gained full resistance to Evusheld™, they are left without effective pre-exposure prophylaxis. We review here arguments to support the growing role of regular immunoglobulin (IG) infusions at protecting against COVID-19. Since there is evidence for neutralizing antibody titers approaching the ones seen in hyperimmune sera, and since some categories of patients at risk for COVID-19 progression are already under preexposure prophylaxis with IG, this cost-effective strategy should be urgently investigated in randomized clinical trials. Surveys of anti-Spike antibody levels in current plasma donations are urgent to forecast the potency of future IG batches.

SUBMITTER: Focosi D 

PROVIDER: S-EPMC9886389 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature